VivoSense develops digital endpoints from wearable devices to enhance clinical trials. By capturing and processing data from these devices, VivoSense transforms raw sensor information into reliable digital endpoints that provide precise insights into patient health and treatment outcomes. The company serves pharmaceutical companies, biotech firms, and research institutions, offering a comprehensive suite of services that includes data design, collection, cleaning, analysis, and reporting. This end-to-end approach allows clients to gain actionable insights, leading to more effective treatments. VivoSense differentiates itself by focusing on the integration of wearable technology and advanced data analytics, aiming to improve the accuracy and efficiency of clinical trials. The goal is to optimize clinical trials and ultimately enhance patient outcomes.